Mumbai Feb 7 (IANS) Drug major Cipla on Wednesday reported a consolidated net profit of Rs 403 crore for the third quarter of fiscal 2017-18 registering a 4.7 per cent annual net profit growth from Rs 385 crore in the same period a year ago.
In a regulatory filing on the BSE the city-based drug maker said consolidated net sales for the quarter under review (Q3) increased 7.6 per cent annually to Rs 3 835 crore from Rs 3 564 crore in the like period a year ago.
Sequentially net profit declined 7.4 per cent from Rs 435 crore a quarter ago and net sales dipped 3.8 per cent from Rs 3 988 crore a quarter ago.
On a standalone basis the parent company s net income grew 23 per cent annually to Rs 419 crore in Q3 from Rs 341 crore in the same period a year ago but declined 26 per cent sequentially from Rs 566 crore a quarter ago.
Similarly standalone income from sales grew annually to 11.7 per cent to Rs 2 892 crore in Q3 but declined 28 per cent sequentially from Rs 2 976 crore.
The company s blue-chip scrip of Rs 2 face value ended on the BSE at Rs 569.15 gaining Rs 3.50 per share from Tuesday s closing price of Rs 565.65 and opening of 582.75 and remained high at the same price after a low of 554.60 per share.
--IANS
fb/qd/bg
